nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—TAAR1—Amine ligand-binding receptors—ADRB1—periodontitis	0.0628	0.0712	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Adrenoceptors—ADRB1—periodontitis	0.0534	0.0605	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Adrenoceptors—ADRB1—periodontitis	0.0475	0.0538	CbGpPWpGaD
Dextroamphetamine—Phenylpropanolamine—ADRB1—periodontitis	0.0445	0.378	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRB1—periodontitis	0.0376	0.319	CrCbGaD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—VIP—periodontitis	0.0375	0.0425	CbGpPWpGaD
Dextroamphetamine—Pseudoephedrine—TNF—periodontitis	0.0357	0.303	CrCbGaD
Dextroamphetamine—SLC6A2—Monoamine Transport—TNFRSF11B—periodontitis	0.0324	0.0367	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Monoamine Transport—TNFRSF11B—periodontitis	0.0287	0.0325	CbGpPWpGaD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—ADRB1—periodontitis	0.0259	0.0294	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0248	0.0281	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Monoamine GPCRs—ADRB1—periodontitis	0.0189	0.0214	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CXCL3—periodontitis	0.0188	0.0214	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Endothelin Pathways—ADRB1—periodontitis	0.0168	0.019	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Monoamine GPCRs—ADRB1—periodontitis	0.0168	0.019	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.0159	0.0181	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Amine ligand-binding receptors—ADRB1—periodontitis	0.0159	0.018	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Amine ligand-binding receptors—ADRB1—periodontitis	0.0141	0.016	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.0124	0.0141	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.0123	0.014	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CXCR2—periodontitis	0.0121	0.0138	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—periodontitis	0.0115	0.013	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Melatonin metabolism and effects—ADRB1—periodontitis	0.0113	0.0128	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CXCL3—periodontitis	0.0107	0.0121	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CXCL3—periodontitis	0.00967	0.011	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CCR2—periodontitis	0.00945	0.0107	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Monoamine Transport—IL1B—periodontitis	0.00942	0.0107	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—ADRB1—periodontitis	0.0094	0.0107	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Monoamine Transport—IL1B—periodontitis	0.00835	0.00946	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—VIP—periodontitis	0.0077	0.00873	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—VIP—periodontitis	0.00699	0.00793	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CXCR2—periodontitis	0.00686	0.00778	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Monoamine Transport—TNF—periodontitis	0.00684	0.00775	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—periodontitis	0.00683	0.00774	CbGpPWpGaD
Dextroamphetamine—SLC6A2—NRF2 pathway—GGT1—periodontitis	0.00646	0.00732	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00626	0.0071	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CXCR2—periodontitis	0.00623	0.00706	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00611	0.00693	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Monoamine Transport—TNF—periodontitis	0.00606	0.00686	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—GGT1—periodontitis	0.00572	0.00649	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCL3—periodontitis	0.00571	0.00648	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00566	0.00641	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00556	0.0063	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CCR2—periodontitis	0.00534	0.00605	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—ADRB1—periodontitis	0.00531	0.00602	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—MMP2—periodontitis	0.00524	0.00594	CbGpPWpGaD
Dextroamphetamine—SLC6A2—NRF2 pathway—AGER—periodontitis	0.00514	0.00583	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00502	0.00569	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCR2—periodontitis	0.00485	0.00549	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00483	0.00548	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—ADRB1—periodontitis	0.00483	0.00547	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL3—periodontitis	0.00477	0.0054	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00471	0.00534	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CCL2—periodontitis	0.00465	0.00528	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—AGER—periodontitis	0.00456	0.00516	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—CXCL8—periodontitis	0.00435	0.00493	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL3—periodontitis	0.00423	0.0048	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00418	0.00474	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VIP—periodontitis	0.00413	0.00468	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00403	0.00457	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—MMP9—periodontitis	0.00394	0.00446	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCR2—periodontitis	0.00368	0.00417	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CXCL8—periodontitis	0.00368	0.00417	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—MMP3—periodontitis	0.00367	0.00416	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00366	0.00415	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00365	0.00413	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00358	0.00406	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00325	0.00369	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00324	0.00367	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00321	0.00364	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00314	0.00356	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00312	0.00354	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCR2—periodontitis	0.00307	0.00348	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCR2—periodontitis	0.00286	0.00325	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00285	0.00323	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ADRB1—periodontitis	0.00285	0.00323	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00279	0.00316	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00277	0.00314	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCR2—periodontitis	0.00273	0.00309	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL3—periodontitis	0.00269	0.00305	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL3—periodontitis	0.00245	0.00277	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL3—periodontitis	0.00239	0.00271	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCR2—periodontitis	0.00239	0.00271	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCL2—periodontitis	0.00239	0.00271	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—ADRB1—periodontitis	0.00238	0.0027	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—GGT1—periodontitis	0.00235	0.00267	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NTRK1—periodontitis	0.00233	0.00265	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—PPARA—periodontitis	0.0022	0.00249	CbGpPWpGaD
Dextroamphetamine—SLC6A2—NRF2 pathway—TGFB1—periodontitis	0.00217	0.00246	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL3—periodontitis	0.00217	0.00246	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MMP3—periodontitis	0.00217	0.00246	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCR2—periodontitis	0.00212	0.00241	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—ADRB1—periodontitis	0.00211	0.00239	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CXCL8—periodontitis	0.00208	0.00236	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—VIP—periodontitis	0.00195	0.00221	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—TGFB1—periodontitis	0.00193	0.00218	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CXCL8—periodontitis	0.00189	0.00214	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—VIP—periodontitis	0.00177	0.002	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCR2—periodontitis	0.00174	0.00197	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—VIP—periodontitis	0.00173	0.00196	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCR2—periodontitis	0.00158	0.00179	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—VIP—periodontitis	0.00157	0.00178	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00155	0.00175	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCR2—periodontitis	0.00154	0.00175	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—PPARA—periodontitis	0.00148	0.00168	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL3—periodontitis	0.00145	0.00164	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL2—periodontitis	0.00141	0.0016	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCR2—periodontitis	0.0014	0.00159	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00137	0.00156	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR2—periodontitis	0.00135	0.00153	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADRB1—periodontitis	0.00134	0.00152	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—PPARA—periodontitis	0.00131	0.00149	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL3—periodontitis	0.00128	0.00146	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—FGF2—periodontitis	0.00128	0.00145	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC52A3—periodontitis	0.00123	0.00139	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR2—periodontitis	0.00123	0.00139	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00122	0.00139	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADRB1—periodontitis	0.00122	0.00138	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR2—periodontitis	0.0012	0.00136	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADRB1—periodontitis	0.00119	0.00135	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL2—periodontitis	0.00118	0.00133	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCL8—periodontitis	0.00112	0.00126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR2—periodontitis	0.00109	0.00123	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00109	0.00123	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADRB1—periodontitis	0.00108	0.00123	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL6—periodontitis	0.00106	0.0012	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL2—periodontitis	0.00105	0.00119	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VIP—periodontitis	0.00104	0.00118	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MMP9—periodontitis	0.00101	0.00114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCR2—periodontitis	0.000931	0.00106	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL8—periodontitis	0.000931	0.00106	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MMP3—periodontitis	0.000929	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VIP—periodontitis	0.000928	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000927	0.00105	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TGFB1—periodontitis	0.000832	0.000943	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCR2—periodontitis	0.000827	0.000938	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL8—periodontitis	0.000827	0.000937	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MMP3—periodontitis	0.000825	0.000935	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000824	0.000934	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR2—periodontitis	0.000724	0.000821	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ACP5—periodontitis	0.000723	0.000819	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB1—periodontitis	0.000721	0.000817	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR2—periodontitis	0.000643	0.000729	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB1—periodontitis	0.000641	0.000726	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—periodontitis	0.000627	0.00071	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL2—periodontitis	0.000604	0.000685	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK1—periodontitis	0.00059	0.000669	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP3—periodontitis	0.000549	0.000622	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL2—periodontitis	0.000537	0.000608	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—periodontitis	0.000526	0.000596	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK1—periodontitis	0.000524	0.000594	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP3—periodontitis	0.000488	0.000553	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—periodontitis	0.000478	0.000541	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—periodontitis	0.000467	0.00053	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—periodontitis	0.000424	0.000481	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GGT1—periodontitis	0.000402	0.000456	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL2—periodontitis	0.000357	0.000405	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF2—periodontitis	0.000323	0.000366	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL2—periodontitis	0.000317	0.000359	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARA—periodontitis	0.000288	0.000326	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF2—periodontitis	0.000287	0.000325	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—periodontitis	0.000282	0.00032	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—periodontitis	0.000268	0.000304	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—periodontitis	0.000255	0.000289	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—periodontitis	0.000251	0.000284	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—periodontitis	0.000238	0.00027	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—periodontitis	0.000227	0.000257	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—periodontitis	0.00021	0.000238	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—periodontitis	0.000187	0.000212	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—periodontitis	0.000187	0.000212	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—periodontitis	0.000159	0.00018	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—periodontitis	0.000141	0.00016	CbGpPWpGaD
